NCT02300532View on ClinicalTrials.gov

Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study)

CompletedOBSERVATIONAL
Enrollment

561

Participants

Timeline

Start Date

January 10, 2013

Primary Completion Date

July 10, 2014

Study Completion Date

March 24, 2015

Conditions
Malignant Glioma
Interventions
OTHER

No intervention

Trial Locations (2)

Unknown

Osaka

Tokyo

All Listed Sponsors
lead

Eisai Co., Ltd.

INDUSTRY

NCT02300532 - Post-Marketing Surveillance of Gliadel 7.7mg Implant (All-case Observational Study) | Biotech Hunter | Biotech Hunter